Dongwha Pharm.Co.Ltd (000020) — Free Cash Flow Generation Index
Dongwha Pharm.Co.Ltd (000020) has a Free Cash Flow Generation Index of 0.27x as of December 2025. Free cash flow of ₩2.64 Billion represents 0% of operating cash flow (₩9.70 Billion). See 000020 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Dongwha Pharm.Co.Ltd Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for Dongwha Pharm.Co.Ltd across 12 annual periods. Explore Dongwha Pharm.Co.Ltd (000020) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Dongwha Pharm.Co.Ltd (2011–2025)
Year-by-year Free Cash Flow Generation Index for Dongwha Pharm.Co.Ltd. For the full company profile including market capitalisation, see market cap of Dongwha Pharm.Co.Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.52x | ₩-39.60 Billion | ₩15.70 Billion | ₩55.30 Billion | ▼ -2708.0% |
| 2023 | 0.10x | ₩2.82 Billion | ₩29.17 Billion | ₩26.35 Billion | ▼ -69.0% |
| 2022 | 0.31x | ₩9.13 Billion | ₩29.22 Billion | ₩18.43 Billion | ▲ +0.0% |
| 2021 | 0.31x | ₩11.26 Billion | ₩36.03 Billion | ₩21.94 Billion | ▼ -26.2% |
| 2020 | 0.42x | ₩22.11 Billion | ₩52.23 Billion | ₩34.25 Billion | ▼ -27.7% |
| 2019 | 0.59x | ₩7.78 Billion | ₩13.28 Billion | ₩4.80 Billion | ▼ -46.7% |
| 2016 | 1.10x | ₩27.99 Billion | ₩25.48 Billion | ₩2.50 Billion | ▲ +5.1% |
| 2015 | 1.04x | ₩20.72 Billion | ₩19.83 Billion | ₩885.50 Million | ▼ -4.5% |
| 2014 | 1.09x | ₩14.79 Billion | ₩13.51 Billion | ₩1.28 Billion | ▼ -21.6% |
| 2013 | 1.40x | ₩11.45 Billion | ₩8.21 Billion | ₩3.24 Billion | ▲ +11.0% |
| 2012 | 1.26x | ₩31.71 Billion | ₩25.23 Billion | ₩6.48 Billion | ▲ +4.9% |
| 2011 | 1.20x | ₩55.39 Billion | ₩46.24 Billion | ₩9.15 Billion | — |